Life Technologies to Present at Upcoming Investment Conferences in February
CARLSBAD, Calif., Jan. 26, 2012 /PRNewswire/ — Life Technologies Corporation (NASDAQ: LIFE) today announced it will webcast the company’s presentations at the following upcoming investment conferences in February.
Life Technologies will present at the Leerink Swann 2012 Global Healthcare Conference on Thursday, February 16 at 8:30 a.m. ET.
Life Technologies will also present at the 2012 RBC Capital Markets’ Global Healthcare Conference on Wednesday, February 29 at 9:30 a.m. ET.
David Hoffmeister, Life Technologies’ Senior Vice President and Chief Financial Officer, will present at the conferences on behalf of the company. These webcasts may be accessed in the Investor Relations section of the Life Technologies website at ir.lifetechnologies.com/events.cfm.
Additionally, Life Technologies will attend the 2012 Citi Global Health Care Conference on Tuesday, February 28.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies’ industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, GIBCO, Ambion, Molecular Probes and Taqman products. Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 4,000 patents and exclusive licenses. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.
SOURCE Life Technologies